AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Markowska, J Fischer, N Warchol, JB Fischer, Z
Citation: J. Markowska et al., Detection of Chlamydia trachomatis infection in women with CIN and invasive carcinoma. Controversial results of different methods, EUR J GYN O, 22(2), 2001, pp. 134-136

Authors: Bar, JK Harlozinska, A Sedlaczek, P Kasiak, J Markowska, J
Citation: Jk. Bar et al., Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infectionin cervical carcinomas and cervical dysplasias, ANTICANC R, 21(2A), 2001, pp. 1001-1006

Authors: Markowska, J Wilkoszarska, J Emerich, J Debniak, J Popiela, A Panszczak, M Kornafel, J Rossochacka, B Fisher, Z Goluda, M Malecki, P
Citation: J. Markowska et al., Factors influencing period of time between negative second-look laparotomyand ovarian carcinoma recurrence. Multicenter study in Poland, EUR J GYN O, 21(2), 2000, pp. 164-167

Authors: Van Dalen, A Favier, J Baumgartner, L Hasholzner, U De Bruijn, H Dobbler, D Dombi, VH Fink, D Giai, M Mcging, P Harlozinska, A Kainz, C Markowska, J Molina, R Sturgeon, C Bowman, A Einarsson, R
Citation: A. Van Dalen et al., Serum levels of CA 125 and TPS during treatment of ovarian cancer, ANTICANC R, 20(6D), 2000, pp. 5107-5108

Authors: van Dalen, A Favier, J Burges, A Hasholzner, U de Bruijn, HWA Dobler-Girdziunaite, D Dombi, VH Fink, D Giai, M McGing, P Harlozinska, A Kainz, C Markowska, J Molina, R Sturgeon, C Bowman, A Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients, GYNECOL ONC, 79(3), 2000, pp. 444-450

Authors: Zygmunt, A Madry, R Markowska, J Fischer, Z
Citation: A. Zygmunt et al., Estimation of the usefulness of neoplastic markers TPS and CA 125 in diagnosis and monitoring of ovarian cancer, EUR J GYN O, 20(4), 1999, pp. 298-301

Authors: Markowska, J Fischer, N Filas, V Fischer, Z Breborowicz, J Markowski, M
Citation: J. Markowska et al., The role of Chlamydia trachomatis infection in cervical cancer development, EUR J GYN O, 20(2), 1999, pp. 144-146

Authors: Van Dalen, A Favier, J Baumgartner, L Hasholzner, U De Bruijn, H Dobbler, D Dombi, VH Fink, D Giai, M McGing, P Harlozinska, A Kainz, C Markowska, J Molina, R Sturgeon, C Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients, ANTICANC R, 19(4A), 1999, pp. 2523-2526

Authors: Zygmunt, A Markowska, J Fischer, N
Citation: A. Zygmunt et al., Significance of tissue polypeptide specific antigen (TPS) in diagnosis andmonitoring of treatment in ovarian cancer, EUR J GYN O, 19(5), 1998, pp. 484-486
Risultati: 1-9 |